A breakthrough design for solid tumors: CAR T cells deliver IL-12 and PD-L1 blocker Chimeric antigen receptor (CAR) T cell therapy has transformed treatments for certain blood cancers, but solid tumors such as ovarian, prostate, breast, and pancreatic cancers have posed stubborn challenges. A collaborative effort from USC Norris Comprehensive Cancer Center and City of…